Cartesian Growth Corp II Files Proxy Statement

Ticker: REEUF · Form: DEF 14A · Filed: Oct 24, 2024 · CIK: 1889112

Cartesian Growth Corp II DEF 14A Filing Summary
FieldDetail
CompanyCartesian Growth Corp II (REEUF)
Form TypeDEF 14A
Filed DateOct 24, 2024
Risk Levellow
Pages16
Reading Time19 min
Key Dollar Amounts$0.0001, $150,000, $0.03, $250,000, $0.05
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, blank-check-company

Related Tickers: IPOE

TL;DR

Cartesian Growth Corp II (IPOE) filed its DEF 14A proxy statement for the Nov 6 meeting. Shareholders get the lowdown.

AI Summary

Cartesian Growth Corp II (ticker: IPOE) is filing a definitive proxy statement (DEF 14A) on October 24, 2024, for its annual meeting on November 6, 2024. The company, incorporated in Delaware with its principal office in New York, is a blank check company focused on real estate and construction. No filing fee was required for this submission.

Why It Matters

This filing provides shareholders with essential information regarding the upcoming annual meeting, including voting matters and company performance, allowing them to make informed decisions.

Risk Assessment

Risk Level: low — This is a routine proxy filing for an annual meeting, not indicating any unusual financial or operational risks.

Key Numbers

  • 20241024 — Filing Date (Date the DEF 14A was filed with the SEC.)
  • 20241106 — Meeting Date (Date of the shareholder meeting for which the proxy is being issued.)

Key Players & Entities

  • Cartesian Growth Corp II (company) — Registrant
  • 0001104659-24-111198 (filing_id) — Accession Number
  • 20241024 (date) — Filing Date
  • 20241106 (date) — Meeting Date
  • 505 FIFTH AVENUE, 15TH FLOOR NEW YORK, NY 10017 (address) — Company Address

FAQ

What is the purpose of this DEF 14A filing?

The purpose of this DEF 14A filing is to provide shareholders of Cartesian Growth Corp II with information required in a proxy statement for their annual meeting.

When is the shareholder meeting scheduled?

The shareholder meeting is scheduled for November 6, 2024.

What is the company's primary business focus?

Cartesian Growth Corp II is a blank check company focused on real estate and construction.

Where is Cartesian Growth Corp II located?

The company's business and mail address is 505 Fifth Avenue, 15th Floor, New York, NY 10017.

Was there a filing fee for this document?

No fee was required for this filing, as indicated by the 'x No fee required' checkbox.

Filing Stats: 4,712 words · 19 min read · ~16 pages · Grade level 20 · Accepted 2024-10-24 17:25:29

Key Financial Figures

  • $0.0001 — the Class A ordinary shares, par value $0.0001 per share, of the Company (“Class
  • $150,000 — 25, the lesser of (i) an aggregate of US$150,000 and (ii) US$0.03 per public share that
  • $0.03 — ) an aggregate of US$150,000 and (ii) US$0.03 per public share that remains outstandi
  • $250,000 — 25, the lesser of (i) an aggregate of US$250,000 and (ii) US$0.05 per public share that
  • $0.05 — ) an aggregate of US$250,000 and (ii) US$0.05 per public share that remains outstandi
  • $5,000,001 — to have net tangible assets of at least $5,000,001, upon consummation of the Company&rsquo
  • $183,134,157.59 million — te. Based on the approximate amount of $183,134,157.59 million held in the Trust Account as of October
  • $11.54 — the Trust Account will be approximately $11.54 at the time of the Extraordinary Genera
  • $11.515 — Ordinary Share on October 23, 2024 was $11.515 per share. The Company cannot assure sh
  • $100,000 — e Company (less taxes payable and up to $100,000 of interest to pay dissolution expenses

Filing Documents

From the Filing

DEF 14A 1 tm2425699d6_def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to §240.14a-12 CARTESIAN GROWTH CORPORATION II (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): x No fee required. ¨ Fee paid previously with preliminary materials. ¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. CARTESIAN GROWTH CORPORATION II 505 Fifth Avenue, 15th Floor New York, New York 10017 PROXY STATEMENT FOR EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS IN LIEU OF ANNUAL MEETING OF CARTESIAN GROWTH CORPORATION II Dear Shareholders of Cartesian Growth Corporation II: You are cordially invited to attend the Extraordinary General Meeting in lieu of an Annual Meeting (the “Extraordinary General Meeting”) of shareholders of Cartesian Growth Corporation II, a Cayman Islands exempted company (the “Company,” “CGC II,” “we,” “us” or “our”), to be held on November 6, 2024, at 11:00 a.m. local time, at the offices of Greenberg Traurig, P.A., 333 S.E. 2nd Avenue, Miami, Florida 33131, or at such other time, on such other date and at such other place to which the meeting may be postponed or adjourned. The formal meeting notice and proxy statement for the Extraordinary General Meeting are attached. Please promptly submit your proxy vote by completing, dating, signing and returning the enclosed proxy, so that your shares will be represented at the Extraordinary General Meeting. It is strongly recommended that you complete and return your proxy card before the Extraordinary General Meeting date to ensure that your shares will be represented at the Extraordinary General Meeting. Instructions on how to vote your shares are on the proxy materials you received for the Extraordinary General Meeting. The Extraordinary General Meeting is being held to consider and vote upon the following proposals: (a) as a special resolution, to amend the Company’s Amended and Restated Memorandum and Articles of Association (the “Charter”) pursuant to an amendment to the Charter in the form set forth in Annex A of the accompanying proxy statement to extend the date by which the Company must (1) effect a merger, share exchange, asset acquisition, share purchase, or reorganization or engaging in any other similar business combination with one or more businesses or entities, which we refer to as our initial business combination, (2) cease its operations except for the purpose of winding up if it fails to complete such initial business combination, and (3) redeem all of the Class A ordinary shares, par value $0.0001 per share, of the Company (“Class A Ordinary Shares”), included as part of the units sold in the Company’s initial public offering that was consummated on May 10, 2022 (the “IPO”) if it fails to complete such initial business combination, from November 10, 2024 (the “Current Termination Date”) to up to November 5, 2025, by electing to extend the date to consummate an initial business combination on a monthly basis for up to twelve (12) times by an additional one month each time (other than the first period, which shall consist of 25 days), unless the closing of the Company’s initial business combination has occurred (such applicable later date, the “Extended Date” and such proposal, the “Extension Proposal”), without the need for any further approval of the Company’s shareholders, provided that CGC II Sponsor LLC (the “Sponsor”) (or its affiliates or permitted designees) will deposit into the trust account established in connection with the IPO (the “Trust Account”) (x) for each such one-month period (other than the first period, which shall consist of 25 days) from November 10, 2024 (exclusive) to May 5, 2025, the lesser of (i) an aggregate of US$150,000 and (ii) US$0.03 per public share that remains outstanding and is not redeemed prior to such one-month (other than the first period, which shall consist of 25 days) extension; and (y) for each such one-month period from May 5, 2025 (exclusive) to November 5, 2025, the lesser of (i) an aggregate of US$250,000 and (ii) US$0.05 per public share that remains outstanding and is not redeemed

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.